We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

194 hedge funds and large institutions have $149M invested in Editas Medicine in 2025 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 57 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

492% more call options, than puts

Call options by funds: $4.92M | Put options by funds: $830K

64% more capital invested

Capital invested by funds: $90.9M → $149M (+$58.4M)

4% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 23

0% more funds holding

Funds holding: 194 → 194 (0)

1.47% less ownership

Funds ownership: 49.34% → 47.87% (-1.5%)

18% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 57

Holders
194
Holders Change
–
Holders Change %
0%
% of All Funds
2.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
47
Reduced
57
Closed
23
Calls
$4.92M
Puts
$830K
Net Calls
+$4.09M
Net Calls Change
+$2.85M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$3.35M
2
N
Nuveen
North Carolina
+$3.19M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.97M
4
Two Sigma Investments
Two Sigma Investments
New York
+$1.71M
5
Walleye Capital
Walleye Capital
New York
+$1.1M

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$4.3M
2
WP
Woodline Partners
California
-$1.86M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$1.32M
4
Morgan Stanley
Morgan Stanley
New York
-$929K
5
Citadel Advisors
Citadel Advisors
Florida
-$772K
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$1.24M -$99.1K -35,510 -9%
Millennium Management
27
Millennium Management
New York
$1.17M -$4.3M -1,540,652 -82%
SPS
28
Susquehanna Portfolio Strategies
Pennsylvania
$1.07M +$861K +308,334 New
Wellington Management Group
29
Wellington Management Group
Massachusetts
$1.02M +$824K +295,257 New
CSS
30
Cubist Systematic Strategies
Connecticut
$994K +$763K +273,393 +2,089%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$918K +$59.3K +21,260 +9%
XT
32
XTX Topco
Cayman Islands
$903K +$355K +127,176 +96%
HWAM
33
Hennion & Walsh Asset Management
New Jersey
$839K -$12.3K -4,401 -2%
Simplex Trading
34
Simplex Trading
Illinois
$804K +$266K +95,406 +70%
Ameriprise
35
Ameriprise
Minnesota
$653K +$525K +188,144 New
Barclays
36
Barclays
United Kingdom
$649K -$34.8K -12,480 -6%
Cambridge Investment Research Advisors
37
Cambridge Investment Research Advisors
Iowa
$619K +$4.98K +1,785 +1%
AllianceBernstein
38
AllianceBernstein
Tennessee
$581K -$45.1K -16,160 -9%
Raymond James Financial
39
Raymond James Financial
Florida
$569K -$50.9K -18,230 -10%
IC
40
IEQ Capital
California
$523K -$10.8K -3,857 -2%
GAA
41
Green Alpha Advisors
Colorado
$508K -$68K -24,370 -14%
Wells Fargo
42
Wells Fargo
California
$445K -$21.5K -7,696 -6%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$425K -$11.9K -4,273 -3%
Los Angeles Capital Management
44
Los Angeles Capital Management
California
$408K -$51K -18,289 -13%
D.E. Shaw & Co
45
D.E. Shaw & Co
New York
$403K +$16.9K +6,066 +6%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$346K +$4.79K +1,717 +2%
HSBC Holdings
47
HSBC Holdings
United Kingdom
$326K +$120K +42,870 +81%
T. Rowe Price Associates
48
T. Rowe Price Associates
Maryland
$300K +$92.3K +33,083 +62%
Deutsche Bank
49
Deutsche Bank
Germany
$275K +$27.1K +9,717 +14%
Russell Investments Group
50
Russell Investments Group
United Kingdom
$273K +$207K +74,042 +1,636%
1
2
3 4 5

EDIT Hedge Fund Activity: Q3 2025 in Review

194 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2025, worth a combined $149M — up 64% from $90.9M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new EDIT positions and 23 closed out — a net gain of 1 holder — while 47 added to existing stakes and 57 trimmed.

The largest buyer was BlackRock, adding an estimated $3.35M. The largest seller was Millennium Management, cutting an estimated $4.3M.

  • 194 institutional investors held Editas Medicine (EDIT) as of Q3 2025, unchanged from Q2 2025.
  • Funds reported $149M of Editas Medicine stock for Q3 2025, up 64% quarter-over-quarter.
  • 24 funds opened new Editas Medicine positions in Q3 2025 and 23 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2025 was BlackRock, an estimated $3.35M added.
  • The largest Editas Medicine seller in Q3 2025 was Millennium Management, an estimated $4.3M sold.

Based on aggregated 13F filings for Q3 2025.